Latest News

Rising medical debt burden among insured Americans and systemic causes.

Healthcare workforce understaffing driven by profit maximization and consolidation.

2024 federal healthcare policy priorities: 340B reform, PBM oversight, and telehealth.

PDABs and upper-payment limits risk restricting medication access despite affordability intentions.

$100 billion 340B program lacks patient accountability; reform needed for charitable care obligations.

PDAB state implementation variations and how patients can engage in the process.

CMS's $9B remedy to hospitals after SCOTUS 340B ruling lacks enforcement of charitable care requirements.

Payers face regulatory scrutiny for systematic coverage denials and prior authorization abuse.

Introduction to PDABs: structure, function, and importance for patient medication access.

340B reform must prioritize patients: charity care obligations and medical debt reduction.

Hospital price transparency and 340B lack accountability while patients face medical debt.

Payers use prior authorization and step therapy to deny care, driving health disparities.

Nursing shortages and hospital consolidation together degrade patient care and access.

ADAP Fireside Chat addresses counterfeit medications, 340B reform, and public health workforce sustainability.

S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

85,000+ fake HIV medication bottles distributed through counterfeiting rings endanger patient safety.

Pharmaceutical industry changes to 340B implementation impact pricing and accessibility for covered entities.

AMA survey: 93% of providers say prior authorizations delay care with 91% reporting negative clinical impact.

Copay accumulator programs block patient assistance from counting toward deductibles; HELP Copays Act needed.

CANN reflects on 2021 advocacy spanning 340B drug pricing, HIV, hepatitis C, and substance use disorder policy.